ARCHIVES

Gleevec Decreases Recurrence Of Gastrointestinal Tumor

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

August 31, 2007

Bush Proposes $27.9 Billion for NIH, Plus $1.4B Reprogram From FY03

February 7, 2003

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990